Squarepoint Ops LLC Moderna, Inc. Call Options Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

Call Options

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $22.6 Million - $44.4 Million	354,800 Added 326.4%	463,500 $31 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $20.6 Million - $33.9 Million	-203,400 Reduced 65.17%	108,700 $12.9 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $426,850 - $577,200	-5,000 Reduced 1.58%	312,100 $33.3 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $4.96 Million - $7.45 Million	-71,300 Reduced 18.36%	317,100 $31.5 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $25.3 Million - $34.3 Million	213,900 Added 122.58%	388,400 $47.2 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $14.2 Million - $20.6 Million	104,400 Added 148.93%	174,500 $26.8 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $3.84 Million - $6.81 Million	-32,400 Reduced 31.61%	70,100 $12.6 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $4.95 Million - $8.14 Million	41,900 Added 69.14%	102,500 $12.1 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $4.33 Million - $6.53 Million	37,000 Added 156.78%	60,600 $8.66 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $227,628 - $423,090	1,800 Added 8.26%	23,600 $4.07 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $6.57 Million - $10.7 Million	-29,100 Reduced 57.17%	21,800 $5.54 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $155,330 - $339,129	700 Added 1.39%	50,900 $19.6 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $1.53 Million - $2.77 Million	11,800 Added 30.73%	50,200 $11.8 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $4.19 Million - $7.14 Million	38,400 New	38,400 $5.03 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account